Gynecologic Cancer

No Benefit With Atezolizumab in BRCA1/2-Mutant or HRD Ovarian Cancer

By

Julie Ehlers

Publish Date May 26, 2023

Adding atezolizumab to standard treatment did not improve PFS in patients with advanced ovarian cancer and BRCA1/2 mutations or HRD.

Food Deserts, Swamps Linked to Increased Risk of Death From Obesity-Related Cancers

By

Andrea S. Blevins Primeau, PhD, MBA

Publish Date May 12, 2023

US counties with food deserts or food swamps tend to have higher rates of death from obesity-related cancers, a study suggests.

Camonsertib-PARP Inhibitor Combos May Meet Unmet Need in Advanced Solid Tumors

By

Jessica Nye, PhD

Publish Date May 4, 2023

Combining camonsertib with PARP inhibitors may be an effective strategy for treating advanced solid tumors, a study suggests.

Could Shopping Data Be Used to Predict Cancer and Diagnose It Earlier?

By

Carina Storrs, PhD

Publish Date May 1, 2023

A recent study suggested that shopping data may help predict the risk of cancer. Now, researchers are exploring the implications of that finding.

Lee Fatigue Scale a Variable in Predicting Morning Fatigue Severity After Chemotherapy

By

Vicki Moore, PhD

Publish Date April 27, 2023

Researchers sought to determine the relationship between individual items and total score on the Lee Fatigue Scale and morning fatigue after chemotherapy.